Guided Therapeutics (GTHP) Cash from Investing Activities Growth (1y) (2012 - 2022)
Guided Therapeutics (GTHP) Cash from Investing Activities Growth (1y) (2012 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -15.64% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -514.42% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -87.14% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -73.71% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -12.26% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 618.55% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 48.43% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 91.33% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 0.00% |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 25.00% |
| Mar 31, 2022 | -1,300.00% |
| Sep 30, 2021 | -400.00% |
| Dec 31, 2015 | 0.00% |
| Sep 30, 2015 | 92.00% |
| Dec 31, 2014 | -250.00% |
| Sep 30, 2014 | -150.00% |
| Mar 31, 2014 | 96.04% |
| Dec 31, 2013 | 107.14% |
| Sep 30, 2013 | 93.10% |
| Mar 31, 2013 | 22.31% |
| Dec 31, 2012 | 78.13% |
| Sep 30, 2012 | 52.15% |
| Jun 30, 2012 | -190.79% |
| Mar 31, 2012 | -88.41% |